Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Basal Cell 6 Lung Neoplasms 4 Breast Neoplasms 3 Skin Neoplasms 2 Precancerous Conditions 2 Pancreatic Neoplasms 2 Neoplasms 2 Keratosis, Actinic 2 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Telangiectasis 1 Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Rosacea 1 Recurrent respiratory papillomatosis 1 Prostatic Neoplasms 1 Port-Wine Stain 1 Pancreatic Intraductal Neoplasms 1 Non-melanoma Skin Cancer 1 Nevus, Pigmented 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Mouth Neoplasms 1 Mouth Diseases 1 Mixed Tumor, Malignant 1 Mesothelioma, Malignant 1 Melanoma 1 Lichen Planus, Oral 1 Leukoplakia, Oral 1

Interventions

Cyclophosphamide 87 fludarabine 77 fludarabine phosphate 45 Tacrolimus 45 Whole-Body Irradiation 42 Mycophenolic Acid 42 Busulfan 35 Melphalan 32 Antilymphocyte Serum 24 Methotrexate 23 thymoglobulin 22 Standard of Care 22 Rituximab 22 venetoclax 20 Thiotepa 20 Sirolimus 20 Azacitidine 20 Stem Cell Transplantation 18 Granulocyte Colony-Stimulating Factor 18 Practice Guidelines as Topic 17 Cytarabine 16 Bortezomib 16 Nivolumab 15 Filgrastim 15 Specimen Handling 14 Dexamethasone 14 Blood Specimen Collection 14 Cyclosporine 13 Surveys and Questionnaires 12 Mesna 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hematologic Neoplasms × Tomography, Optical Coherence × Clear all

NCT04188912 2025-10-02

CATCH

Fred Hutchinson Cancer Center

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡